🟢 CalciMedica is trading 10.25% up today after Nasdaq closed its market-value compliance matter — delisting concerns ease

CalciMedica is trading 10.25% up at $2.21 after Nasdaq closed its market-value compliance matter on September 2, 2026.

• The company satisfied Nasdaq’s alternative stockholders’ equity requirement, reducing immediate delisting concerns.
• The stock remains subject to Nasdaq’s $1.00 minimum-bid-price requirement, with a September 14, 2026 deadline.
• CalciMedica completed a 1-for-5 reverse split on August 28, 2026; broader biotech strength provides additional sector support.